Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
We review 2024 tax-efficient index fund options and provide practical guidance for incorporating them into a retirement strategy.
24,809 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Bank of America just delivered a standout quarter with revenue and earnings beating estimates and a solid return on t...
A shift is sweeping real estate finance: lenders are resetting terms, buyers are adjusting plans, and landlords are l...
Can AI agents boost ethereum security? This piece explores a new testing ground where intelligent agents probe and pa...
A sweeping housing proposal could unlock an easier path to ownership for many Americans. This guide breaks down what ...
When the government pours billions into quantum research, a surge in quantum stocks often follows. This guide breaks ...
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
In many American cities, affordable homes and Section 8 properties are hard to find. This in-depth guide explains why...
A looked-at moment in media power and money: how a public challenge can ripple into legal fees, PR costs, and real-wo...
A major stake sale in Albertsons by a large hedge fund sparks questions about what insiders know and how it affects t...
After a dramatic fall, Bitcoin traders expect more pain ahead as BTC slips from its peak. This guide breaks down what...
NuScale Power has seen wild swings, but the story isn’t just nostalgia for a boom. This piece breaks down the odds of...